Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An exploratory double-blind, placebo controlled, randomized, 12-week oral dose study to evaluate the effects of MK0736 on atherosclerotic disease biomarkers in lower extremity plaque excised from patients with peripheral arterial disease

Next Previous
Trial Profile

An exploratory double-blind, placebo controlled, randomized, 12-week oral dose study to evaluate the effects of MK0736 on atherosclerotic disease biomarkers in lower extremity plaque excised from patients with peripheral arterial disease

Status: Discontinued
Phase of Trial: Phase I

Latest Information Update: 09 May 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs MK 0736 (Primary)
  • Indications Atherosclerosis; Peripheral arterial disorders
  • Focus Pharmacodynamics
  • Sponsors Merck & Co

Most Recent Events

  • 25 Aug 2008 The expected completion date for this trial is now 1 Aug 2008.
  • 05 Aug 2008 Actual start date changed from Dec 2008 to Aug 2008 as reported by ClinicalTrials.gov.
  • 05 Aug 2008 Patient number amended from 130 to 15 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top